HDFC Pharma And Healthcare Fund Growth

HDFC Pharma And Healthcare Fund Growth

Equity
Sectoral
Very High Risk
1M
6M
1Y
All
NAV: 09 Jan '26
₹17.31
Min. SIP amount
Not Supported
Fund size
₹2,010.77 Cr
Expense ratio
2.10%

Holdings (31)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity11.34%
Divi's Laboratories Ltd.HealthcareEquity8.34%
Lupin Ltd.HealthcareEquity6.40%
Glenmark Pharmaceuticals Ltd.HealthcareEquity6.09%
Max Healthcare Institute Ltd.HealthcareEquity6.07%
Alkem Laboratories Ltd.HealthcareEquity5.89%
Ipca Laboratories Ltd.HealthcareEquity4.61%
Laurus Labs Ltd.HealthcareEquity4.02%
Anthem Biosciences Ltd.HealthcareEquity3.89%
Torrent Pharmaceuticals Ltd.HealthcareEquity3.71%
Aster DM Healthcare Ltd.HealthcareEquity3.56%
Krishna Institute of Medical Sciences LtdHealthcareEquity3.35%
Acutaas Chemicals Ltd.HealthcareEquity2.97%
Cipla Ltd.HealthcareEquity2.89%
Eris Lifesciences Ltd.HealthcareEquity2.83%
Metropolis Healthcare Ltd.HealthcareEquity2.36%
Vijaya Diagnostic Centre Ltd.HealthcareEquity2.30%
Dr. Lal Pathlabs Ltd.HealthcareEquity1.79%
Jubilant Pharmova Ltd.HealthcareEquity1.72%
Thyrocare Technologies Ltd.HealthcareEquity1.65%
Sai Life Sciences Ltd.HealthcareEquity1.62%
Wockhardt Ltd.HealthcareEquity1.59%
Ajanta Pharma Ltd.HealthcareEquity1.32%
Pfizer Ltd.HealthcareEquity1.20%
Global Health Ltd.HealthcareEquity1.20%
Shilpa Medicare Ltd.HealthcareEquity1.16%
Bajaj Healthcare Ltd.HealthcareEquity1.13%
Gland Pharma Ltd.HealthcareEquity1.10%
Rubicon Research Ltd.HealthcareEquity1.03%
Laxmi Dental Ltd.HealthcareEquity0.89%
Piramal Pharma Ltd.HealthcareEquity0.37%
See All

Minimum investments

Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported

Returns and rankings

Annualised returns
Absolute returns
Name3M6M1YAll
Fund returns+2.4%+3.2%+1.1%+73.4%
Category average (Equity Sectoral)-----2.1%--
Rank (Equity Sectoral)331--

Exit load, stamp duty and tax

Exit load

Exit load of 1%, if redeemed within 30 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Check past data

Fund management

DM
Dhruv Muchhal
Sep 2023 - Present
View details

Education
Mr. Dhruv has done B.Com, CA and CFA
Experience
Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Also manages these schemes

NM
Nikhil Mathur
Sep 2023 - Present
View details

Education
Mr. Mathur has done B.Tech and PGDM in Finance
Experience
Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Also manages these schemes

About HDFC Pharma And Healthcare Fund Growth

HDFC Pharma And Healthcare Fund Growth is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 10 Dec 1999. Dhruv Muchhal is the Current Fund Manager of HDFC Pharma And Healthcare Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹9,39,182 Cr and the Latest NAV as of 09 Jan 2026 is ₹17.31. The HDFC Pharma And Healthcare Fund Growth is rated Very High risk. Exit load of 1%, if redeemed within 30 days. ;

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#2 in India
Total AUM₹9,39,181.92 Cr
Date of Incorporation10 Dec 1999
Phone022 – 66316333
Launch Date10 Dec 1999
Address"HDFC House", 2nd Floor, H. T. Parekh Marg, 165-166, BackbayReclamation, Churchgate Mumbai 400020
CustodianHongkong & Shanghai Banking Corporation
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,